Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Self

Showing results (91-100 of 122) with videos related to

Pageof 13
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Chromosomal instability in Barrett's esophagus is related to telomere shorteningJennifer C Finley, Brian J Reid, Robert D Odze, et al.
Journal of Virology|January 30, 2009
Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infectionsAndrea R Stacey, Philip J Norris, Li Qin, et al.
The Journal of Infectious Diseases|April 25, 2001
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDSM M Berrey, T Schacker, A C Collier, et al.
Microbiology and Molecular Biology Reviews : MMBR|November 28, 2014
Tuberculosis vaccines and prevention of infectionThomas R Hawn, Tracey A Day, Thomas J Scriba, et al.
Plos One|June 23, 2011
Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step studyFusheng Li, Adam C Finnefrock, Sheri A Dubey, et al.
The Journal of Infectious Diseases|July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccinePeter Gilbert, Maggie Wang, Terri Wrin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's EsophagusXiaohong Li, Thomas G Paulson, Patricia C Galipeau, et al.
Plos Pathogens|July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
Journal of Immunological Methods|September 8, 2012
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studiesMitzi M Donaldson, Shing-Fen Kao, Leila Eslamizar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2007
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroadsHeather B Jaspan, Coleen K Cunningham, Tim J P Tucker, et al.
Pageof 13

Showing results (91-100 of 122) with videos related to

Sort By:
Pageof 13
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 10, 2006
Chromosomal instability in Barrett's esophagus is related to telomere shorteningJennifer C Finley, Brian J Reid, Robert D Odze, et al.
Journal of Virology|January 30, 2009
Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infectionsAndrea R Stacey, Philip J Norris, Li Qin, et al.
The Journal of Infectious Diseases|April 25, 2001
Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDSM M Berrey, T Schacker, A C Collier, et al.
Microbiology and Molecular Biology Reviews : MMBR|November 28, 2014
Tuberculosis vaccines and prevention of infectionThomas R Hawn, Tracey A Day, Thomas J Scriba, et al.
Plos One|June 23, 2011
Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step studyFusheng Li, Adam C Finnefrock, Sheri A Dubey, et al.
The Journal of Infectious Diseases|July 9, 2010
Magnitude and breadth of a nonprotective neutralizing antibody response in an efficacy trial of a candidate HIV-1 gp120 vaccinePeter Gilbert, Maggie Wang, Terri Wrin, et al.
Cancer Prevention Research (Philadelphia, Pa.)|July 2, 2015
Assessment of Esophageal Adenocarcinoma Risk Using Somatic Chromosome Alterations in Longitudinal Samples in Barrett's EsophagusXiaohong Li, Thomas G Paulson, Patricia C Galipeau, et al.
Plos Pathogens|July 3, 2013
HIV-1 vaccine-induced T-cell responses cluster in epitope hotspots that differ from those induced in natural infection with HIV-1Tomer Hertz, Hasan Ahmed, David P Friedrich, et al.
Journal of Immunological Methods|September 8, 2012
Optimization and qualification of an 8-color intracellular cytokine staining assay for quantifying T cell responses in rhesus macaques for pre-clinical vaccine studiesMitzi M Donaldson, Shing-Fen Kao, Leila Eslamizar, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2007
Inclusion of adolescents in preventive HIV vaccine trials: public health policy and research design at a crossroadsHeather B Jaspan, Coleen K Cunningham, Tim J P Tucker, et al.
Pageof 13